Erik Sulman
Chair, Department of Radiation Oncology · Duke University Hospital
Credentials: · · · · · ·
History
PresentDepartment of Radiation Oncology · Duke University Hospital
- Present
Executive Director of the Duke Cancer Institute Center · Duke University Hospital
PresentDepartment of Radiation Oncology · NYU Grossman School of Medicine
- 2003–2004
Preliminary or Transitional Year
- 1999–2003
Research
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
New England Journal of Medicine · 2015 · 2,511 citations
A randomized trial of bevacizumab for newly diagnosed glioblastoma
New England Journal of Medicine · 2014 · 2,221 citations
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma
Cancer Cell · 2010 · 1,879 citations
35 papers
33 papers
21 papers
18 papers
18 papers
16 papers · 6 as a fellow
16 papers
15 papers
Grants
- 1997–2029
- 2023–2029
Exploiting Cell Fate Transition to Overcome Radiation Resistance in Glioblastoma
National Cancer Institute · R01
Contact PI · $2M · Duke University
- 2023–2028
K12 Training for Clinical and Translational Oncology Researchers
National Cancer Institute · K12
Contact PI · $643.7K · New York University School of Medicine
- 2018–2025
Bidirectional Interaction of Platelets and Tumor Cells in Patients with Glioblastoma
National Cancer Institute · R01
Contact PI · $2.7M · New York University School of Medicine
Clinical trials
- 2025–2030
Principal investigator · Recruiting · Phase 2
RTOG Foundation, Inc.
- 2019–2027
Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma
Principal investigator · Active not recruiting · Phase 2
NYU Langone Health
- 2018–2022
Principal investigator · Completed · Phase 2
NYU Langone Health